EMA Authorised: Victoza (liraglutide) — Novo Nordisk A/S

View source ↗

Summary

The European Medicines Agency authorised Victoza (liraglutide) for the treatment of Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Novo Nordisk A/S. Decision date: 19/11/2024